Evidence map›Paper›PMID 37486777›Full record

ArticleNucleic acids research2023

Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism.

Justyna Sikorska, Yan Hou, Paul Chiurazzi, Tony Siu, Gretchen A Baltus, Payal Sheth, David G McLaren, Quang Truong, Craig A Parish, Daniel F Wyss

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Justyna SikorskaMerck & Co., Inc., Rahway, NJ, USA.ORCID 0000-0002-3836-6708
Yan HouMerck & Co., Inc., Rahway, NJ, USA.
Paul ChiurazziMerck & Co., Inc., Rahway, NJ, USA.
Tony SiuMerck & Co., Inc., Rahway, NJ, USA.
Gretchen A BaltusMerck & Co., Inc., Rahway, NJ, USA.
Payal ShethMerck & Co., Inc., Rahway, NJ, USA.
David G McLarenMerck & Co., Inc., Rahway, NJ, USA.
Quang TruongMerck & Co., Inc., Rahway, NJ, USA.
Craig A ParishMerck & Co., Inc., Rahway, NJ, USA.
Daniel F WyssMerck & Co., Inc., Rahway, NJ, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RIG-I (retinoic acid inducible gene-I) can sense subtle differences between endogenous and viral RNA in the cytoplasm, triggering an anti-viral immune response through induction of type I interferons (IFN) and other inflammatory mediators. Multiple crystal and cryo-EM structures of RIG-I suggested a mechanism in which the C-terminal domain (CTD) is responsible for the recognition of viral RNA with a 5'-triphoshate modification, while the CARD domains serve as a trigger for downstream signaling, leading to the induction of type I IFN. However, to date contradicting conclusions have been reached around the role of ATP in the mechanism of the CARD domains ejection from RIG-I's autoinhibited state. Here we present an application of NMR spectroscopy to investigate changes induced by the binding of 5'-triphosphate and 5'-OH dsRNA, both in the presence and absence of nucleotides, to full length RIG-I with all its methionine residues selectively labeled (Met-[ϵ-13CH3]). With this approach we were able to identify residues on the CTD, helicase domain, and CARDs that served as probes to sense RNA-induced conformational changes in those respective regions. Our results were analyzed in the context of either agonistic or antagonistic RNAs, by and large supporting a mechanism proposed by the Pyle Lab in which CARD release is primarily dependent on the RNA binding event.

Indexed as

Trans-ActivatorsDEAD Box Protein 58Interferon Type IProtein Structure, TertiaryRNA, Double-StrandedRNA, ViralSignal TransductionDEAD Box Protein 58Interferon Type IRNA, Double-StrandedRNA, ViralTrans-Activators

Identifiers

PMID37486777
PMCPMC10516622
OpenAlexW4385226570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.